title: Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin home therapy in a patient with primary immunodeficiency.
authors.forename: Emma
authors.initials: E
authors.lastname: Knight
authors.forename: Emily
authors.initials: E
authors.lastname: Carne
authors.forename: Barbara
authors.initials: B
authors.lastname: Novak
authors.forename: Tariq
authors.initials: T
authors.lastname: El-Shanawany
authors.forename: Paul
authors.initials: P
authors.lastname: Williams
authors.forename: Trevor
authors.initials: T
authors.lastname: Pickersgill
authors.forename: Stephen
authors.initials: S
authors.lastname: Jolles
mesh_terms: D000328:Adult; D017074:Common Variable Immunodeficiency / Q000628:therapy*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000008:administration & dosage*; D007116:Immunization, Passive / Q000379:methods*; D007279:Injections, Subcutaneous; D012646:Self Administration
chemical_list: D006821:Hyaluronoglucosaminidase